Damora Therapeutics, Inc.
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.80 | -10.58 | -5.47 | -3.78 | -3.19 | -3.83 | -1.84 | -1.69 | -1.97 | 0.34 | -0.60 | -0.36 | -0.73 | |
| 0.34 | 0.21 | 0.09 | 0.07 | 0.05 | -0.04 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | – | 0.59 | 0.24 | 0.14 | 0.13 | 0.12 | 0.29 | 0.09 | 0.10 | 0.16 | |
| -1.85 | -5.75 | -1.76 | 0.17 | -0.52 | -0.27 | -0.09 | 0.77 | 0.25 | 10.34 | 0.12 | 0.05 | 0.40 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 7.64 | 8.83 | 5.21 | 5.53 | – | – | – | – | – | -10.48 | – | – | – | |
| 0.16 | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | – | 160.99 | 8.63 | 0.48 | – | |
| 0.11 | -1.49 | -0.34 | 1.63 | -3.19 | -3.83 | -1.84 | -1.69 | -1.97 | 150.83 | 8.03 | 0.12 | 8.67 | |
| -7.80 | -10.58 | -5.47 | -3.78 | -3.19 | -3.83 | -1.84 | -1.69 | -1.97 | 0.34 | -0.60 | -0.36 | -0.73 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.